Heart Rate Observation System effectively reduces NICU infant mortality

NewsGuard 100/100 Score

In a long-running randomized study of over 3,000 preterm infants, those whose care included the Heart Rate Observation System, or HeRO® monitor, experienced greater than 20 percent reduced mortality, effectively saving one infant's life for every 48 who were monitored. The results of this multicenter study of the HeRO monitor, co-sponsored by the National Institutes of Health and Medical Predictive Science Corporation (MPSC), appear in The Journal of Pediatrics.

HeRO is a pioneering monitoring system for premature infants that detects early signs of distress, commonly caused by infection and other potentially life-threatening illnesses. HeRO generates an hourly numeric score that quantifies the prevalence of abnormal patterns in each patient's heart rate and provides a new tool for clinical assessment so that standard diagnostic and therapeutic decisions are better founded.

The study, "Mortality reduction by heart rate characteristic monitoring in very low birth weight neonates: a randomized trial," was conducted from April 2004 to September 2010 at leading neonatal intensive care units (NICU) at the University of Virginia, Wake Forest University, University of Alabama at Birmingham, Vanderbilt University, University of Miami/Jackson Memorial Hospital, Greenville SC Hospital System, Winnie Palmer Children's Hospital and Pennsylvania State University.

There were 152 deaths (10.2 percent) in the group that received standard NICU care and 122 deaths (8.1 percent) in the group that received standard NICU care plus HeRO monitoring, an absolute risk reduction of 2.1 percent. There were no significant differences in demographics between the two groups, nor any of the other outcomes measured by the study.

The study's lead investigator and co-inventor J. Randall Moorman, M.D., a University of Virginia cardiologist, said, "The HeRO monitor is the voice for infants who can't speak for themselves. It's an early warning system for NICU doctors and nurses to get to the right bedside at the right time."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
SGLT2 inhibitors: A game-changer in preventing heart failure and sudden cardiac deaths